Healthy Living: Genomic Profiling

For patients with aggressive prostate cancer, there are limited treatment options.

Once cancer has spread, most doctors rule out surgery and radiation, the standard treatments for early stage prostate cancer.

But now, new advances in testing are helping doctors zero in on therapies besides hormones and chemo to stop advanced cancer in its tracks.

Courtney Hunter has more in Healthy Living.

Despite John’s treatment success, Dr. Mathew cautions patients that genomic profiling is not a magic bullet for everyone.

Sometimes there will be no existing therapies that will be a match.

John says in his case, he’s thankful that when all other treatments failed, the testing delivered a lifesaving option.